Real-world Clinical Outcomes of NSCLC Patients Receiving Neoadjuvant Immunotherapy
Clinical trial NCT06317558 · RECRUITING
Trial details
- NCT number
- NCT06317558
- Sponsor
- Cancer Institute and Hospital, Chinese Academy of Medical Sciences
- Status
- RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2024-03-01
- Primary completion
- 2026-03-01
- Enrollment
- 4000
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.